Earnings Call
Apr 29, 2026
Q1 FY2026
EPS Estimate
1.07
EPS Actual
0.99
Post-Earnings Close
$59.49
Earnings Reaction
-13.2%
GE HealthCare's first quarter of 2026 was a tale of two stories: a top line that performed at the high end of expectations, and a profit line that disappointed due to a confluence of discrete and structural cost pressures. Revenue came in at $5.1 billion, representing 2.9% organic growth, supported by double-digit reported growth in EMEA and Rest of World, mid-single-digit U.S. growth, and China performance that was weak but in line with internal expectations. Adjusted EPS of $0.99 missed the $1.07 consensus estimate, weighed down by approximately $0.16 of tariff impact and roughly $0.05 from a PDx supplier quality issue that has since been resolved. Adjusted EBIT margin of 13.5% was down approximately 150 basis points year-over-year, a result management acknowledged with clear disappointment.
Report generated on May 1, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full GEHC analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.